Biomerica (BMRA.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec23

Biomerica Announces $300 CMS Payment Rate for Infofoods® IBS Test

13:21

Oct15

Biomerica released FY2026 Q1 earnings on October 14, 2025 (EST) with actual revenue of USD 1.38 M and EPS of USD 0.0007

03:00

Aug30

Biomerica released FY2025 Q4 earnings on August 29 (EST), actual revenue USD 749 K, actual EPS USD -0.7298

03:00

Biomerica released FY2025 Annual Earnings on August 29 (EST), actual revenue USD 5.311 M, actual EPS USD -2.1649

03:00

Jul17

Biomerica Releases Investor Presentation

03:21

Jun5

Biomerica Publishes Key Clinical Study on the Efficacy of inFoods IBS Test

12:23

Schedules & Filings

Schedules

Filings

Oct14

Earning Release(EST)

FY2026 Q1 Earning Release (USD) Revenue 1.38 M, Net Income 2 K, EPS 0.0007

Aug29

Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue 749 K, Net Income -1.544 M, EPS -0.7298

Apr21

Reverse Stock Split(EST)

1-for-8 Reverse Stock Split

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change